Alembic Pharma Ltd

NSE: APLLTD · Pharmaceuticals · sector

₹766.40NSE close 2026-10-26

Key numbers

Market cap₹15,064 cr

Price₹766.40

52w high / low₹998 / ₹636

P/E21.7xSector median 27.9x

P/B2.7xSector median 2.9x

Book value₹288.7

Dividend yield1.44%Sector median 0.48%

ROE12.7%Sector median 11.7%

ROCE11.7%Sector median 12.3%

OPM14.2%Sector median 14.0%

Debt / equity0.24xSector median 0.16x

EV/EBITDA14.7xSector median 18.6x

Interest cover8.4x

Current ratio1.75x

Sales growth 3y+9.1%Sector median +9.6%

Profit growth 3y+25.2%Sector median +13.3%

PEG0.85x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹203 cr vs borrowings ₹1,361 cr (FY26): borrowings are higher by ₹1,158 cr.
Operating profit covered interest 8.4x in the last 12 months.
No promoter shares are pledged.
Operating cash flow was below net profit in 1 of the last 5 years (FY25).
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 9% of net profit in the last 12 months.
Debtor days went from 60 (FY24) to 73 (FY26).
Dividend paid in 5 of the last 5 financial years.
Price ₹766.40 on 2026-10-26: -23.2% from the 52-week high, +20.5% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹1,246.85 · low ₹646.55

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1,648	1,693	1,770	1,711	1,910	1,876	1,848	2,150
EBITDA	252	260	272	281	316	251	203	332
OPM %	15.3%	15.4%	15.4%	16.4%	16.5%	13.4%	11.0%	15.4%
Other income	17	10	14	6	7	16	26	15
Net profit	153	138	157	154	185	133	202	173
EPS (₹)	7.79	7.01	7.98	7.85	9.40	6.76	10.31	8.80
Revenue YoY					+15.9%	+10.8%	+4.4%	+25.7%
Profit YoY					+20.4%	-3.9%	+28.5%	+12.1%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	5,306	5,653	6,229	6,672	7,345	7,784
EBITDA	874	708	933	1,021	1,051	1,102
Net profit	546	342	616	583	671	692
EPS (₹)	27.76	17.40	31.33	29.68	34.33	35.27
Revenue growth		+6.5%	+10.2%	+7.1%	+10.1%	+14.1%
Profit growth		-37.3%	+80.1%	-5.3%	+15.0%	+14.8%
Dividend / share (₹)	14.00	10.00	8.00	11.00	11.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+9.1%	+6.4%	+14.1%
Net profit	+25.2%	-10.7%	+14.8%
EPS	+25.4%	-10.8%	–
Share price	–	-16.9% (2y)	-15.5%

Balance sheet

₹ cr	FY22	FY23	FY24	FY25	FY26
Shareholders' equity	–	4,370	4,818	5,191	5,675
Borrowings	–	636	430	1,196	1,361
Cash & equivalents	–	82	127	90	203
Total assets	–	6,183	6,446	7,773	8,763
Fixed assets	–	2,398	2,547	2,524	2,844
Capital work in progress	–	601	524	837	634
Investments	–	71	69	101	113
Receivables	–	1,046	1,025	1,400	1,466
Inventory	–	1,475	1,644	2,288	2,511
Payables	–	680	736	880	835

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	552	724	803	88	783
Cash from investing	-372	-448	-321	-568	-506
Cash from financing	-217	-262	-438	444	-164
Capex	426	443	327	564	495
Free cash flow	127	281	476	-476	288

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY22	FY23	FY24	FY25	FY26
ROE %	–	7.8%	12.8%	11.2%	11.8%
ROCE %	–	8.7%	13.1%	12.3%	11.2%
Debtor days	–	68	60	77	73
Inventory days	–	315	350	466	462
Payable days	–	145	157	179	154
Cash conversion cycle (days)	–	238	253	364	381
Working capital days	–	82	95	92	97

Shareholding

Holder	% (2026-09-30)
Promoters	69.87%
FIIs	4.55%
DIIs	15.43%
of which Mutual funds	8.50%
of which Insurance	6.46%
Government	0.00%
Public (non-institutions)	10.15%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	69.61%	69.67%	69.67%	69.74%	69.74%	69.74%	69.87%	69.87%

Promoter group	%
Nirayu Private Limited	35.78%
Alembic Limited	28.54%
Chirayu Ramanbhai Amin	2.13%
Malika Chirayu Amin	1.53%
Pranav Chirayu Amin	0.51%
Shaunak Chirayu Amin	0.51%
Udit Chirayu Amin	0.51%
Chirayu Ramanbhai Amin HUF	0.11%
Gallup Trust (Pranav Chirayu Amin)	0.05%
Inaaya Shaunak Amin	0.04%
Naintara Shaunak Amin	0.04%
Barkha Pranav Amin	0.03%
Krupa Shaunak Amin	0.03%
Satori Trust (Chirayu Ramanbhai Amin)	0.03%
Ranvir Pranav Amin	0.02%

Public holders above 1%	%
Life Insurance Corporation Of India	4.32%
Dsp Small Cap Fund	2.83%
Icici Prudential Healthcare Fund	1.77%
Kotak Small Cap Fund	1.74%

86,532 shareholders. Pledged: 0.00% of promoter shares.

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
APLLTD	₹15,064 cr	21.7x	2.7x	12.7%	11.7%	14.2%	+9.1%	1.44%

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2026-07-29	Dividend	Dividend - Rs 12 Per Share
2025-07-29	Dividend	Dividend - Rs 11 Per Share
2024-07-15	Dividend	Dividend - Rs 11 Per Share
2023-07-28	Dividend	Dividend - Rs 8 Per Share
2022-08-17	Dividend	Interim Dividend - Rs 10 Per Share
2021-07-19	Dividend	Annual General Meeting/Dividend - Rs 14 Per Share
2020-03-16	Dividend	Interim Dividend - Rs 7 Per Share Special Dividend - Rs 3 Per Share
2019-07-18	Dividend	Annual General Meeting/Dividend Rs 5.50/-
2018-07-18	Dividend	Annual General Meeting/Dividend- Rs 4 Per Share (Purpose Revised)
2017-07-11	Dividend	Annual General Meeting/Dividend -Rs 4/- Per Share
2016-07-20	Dividend	Annual General Meeting/Dividend - Rs 4/- Per Share
2015-07-22	Dividend	Annual General Meeting/ Dividend - Rs 3.50/- Per Share
2014-07-17	Dividend	Annual General Meeting / Dividend - Rs 3/- Per Share
2013-07-29	Dividend	Annual General Meeting And Dividend Rs.2.50 Per Share
2012-07-31	Dividend	Annual General Meeting / Dividend Rs 1.40 Per Share

Documents

Links go to the original files on the exchange website.

About the company

Manufacturing of Pharmaceuticals: Manufacture and trade of active pharmaceutical intermediates and finished dosage formulations


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	APLLTD
BSE code	533573
ISIN	INE901L01018
Face value	₹2.0
Incorporated	2010-06-16
Website	www.alembicpharmaceuticals.com
Plants (India / abroad)	12 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.